An official website of the United States government
Number of SEER-MHOS (1998-2021) Respondents (Age 65+) by First Cancer Site
| First Cancer (#) | Number of linked Patients with One or More survey (Group A) |
More than one survey* (Subset of Group A) |
Survey before Cancer Diagnosis (Group B) |
Survey both before and after Cancer Diagnosis** (Subset of Group B) |
Survey after Cancer Diagnosis (Group C) |
||||
|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | ||
| Prostate (28010) | 63,056 | 30,363 | (48.15) | 21,570 | (34.21) | 4,817 | (7.64) | 46,295 | (73.42) |
| Breast (26000) | 57,262 | 28,547 | (49.85) | 21,058 | (36.77) | 4,263 | (7.44) | 40,456 | (70.65) |
| Colorectal (21041-21052) | 34,055 | 16,131 | (47.37) | 16,291 | (47.84) | 2,448 | (7.19) | 20,209 | (59.34) |
| Lung and bronchus (22030) | 32,342 | 13,667 | (42.26) | 25,979 | (80.33) | 1,900 | (5.87) | 8,255 | (25.52) |
| Ovary (27040) | 3,273 | 1,508 | (46.07) | 2,026 | (61.90) | 194 | (5.93) | 1,441 | (44.03) |
| Uterus (27020, 27030) | 10,275 | 4,997 | (48.63) | 3,633 | (35.36) | 658 | (6.40) | 7,300 | (71.05) |
| Cervix (27010) | 1,461 | 638 | (43.67) | 464 | (31.76) | 50 | (3.42) | 1,047 | (71.66) |
| Bladder (29010) | 17,002 | 8,271 | (48.65) | 9,081 | (53.41) | 1,431 | (8.42) | 9,352 | (55.01) |
| Melanomas – skin (25010) | 17,601 | 9,196 | (52.25) | 8,212 | (46.66) | 1,461 | (8.30) | 10,809 | (61.41) |
| Head and Neck (20010-20100,22010,22020) | 8,138 | 3,681 | (45.23) | 3,944 | (48.46) | 574 | (7.05) | 4,768 | (58.59) |
| Kidney and Renal pelvis (29020) | 8,492 | 4,006 | (47.17) | 4,509 | (53.10) | 683 | (8.04) | 4,665 | (54.93) |
| Non-Hodgkin's lymphomas - nodal and extranodal (33041,33042) |
11,432 | 5,480 | (47.94) | 6,719 | (58.77) | 856 | (7.49) | 5,568 | (48.71) |
| Stomach (21020) | 4,235 | 1,807 | (42.67) | 3,048 | (71.97) | 246 | (5.81) | 1,432 | (33.81) |
| Pancreas (21100) | 6,483 | 2,760 | (42.57) | 5,956 | (91.87) | 215 | (3.32) | 742 | (11.45) |
* At least one survey must be two years after first survey.
** Number of individuals with a survey before their first cancer diagnosis and also a survey after their first cancer diagnosis.
Note:
- The denominator for the percentages that appear in columns 3 through 6 is the Number of linked patients with one or more survey by cancer site (column 2).
- The groups in columns 4 through 6 are not mutually exclusive, therefore, the percentages do not sum to 100.